These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18230562)

  • 21. High-dose tigecycline and colistin for successful treatment of disseminated carbapenem-resistant Klebsiella pneumoniae infection in a liver transplant recipient.
    Dan JM; Mendler MH; Hemming AW; Aslam S
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25378111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli.
    Docobo-Pérez F; Nordmann P; Domínguez-Herrera J; López-Rojas R; Smani Y; Poirel L; Pachón J
    Int J Antimicrob Agents; 2012 Mar; 39(3):251-4. PubMed ID: 22154856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae.
    Daly MW; Riddle DJ; Ledeboer NA; Dunne WM; Ritchie DJ
    Pharmacotherapy; 2007 Jul; 27(7):1052-7. PubMed ID: 17594211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First case of resistance to tigecycline by Klebsiella pneumoniae in a European University Hospital.
    Neonakis IK; Stylianou K; Daphnis E; Maraki S
    Indian J Med Microbiol; 2011; 29(1):78-9. PubMed ID: 21304206
    [No Abstract]   [Full Text] [Related]  

  • 25. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
    Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
    Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nested case-control study of the emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae.
    Nigo M; Cevallos CS; Woods K; Flores VM; Francis G; Perlman DC; Revuelta M; Mildvan D; Waldron M; Gomez T; Koshy S; Jodlowski T; Riley W; Ruhe JJ
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5743-6. PubMed ID: 23979745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections.
    Falagas ME; Vardakas KZ; Tsiveriotis KP; Triarides NA; Tansarli GS
    Int J Antimicrob Agents; 2014 Jul; 44(1):1-7. PubMed ID: 24602499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thanatin activity on multidrug resistant clinical isolates of Enterobacter aerogenes and Klebsiella pneumoniae.
    Pagès JM; Dimarcq JL; Quenin S; Hetru C
    Int J Antimicrob Agents; 2003 Sep; 22(3):265-9. PubMed ID: 13678832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs.
    Mezzatesta ML; Caio C; Gona F; Cormaci R; Salerno I; Zingali T; Denaro C; Gennaro M; Quattrone C; Stefani S
    Int J Antimicrob Agents; 2014 Aug; 44(2):112-6. PubMed ID: 25059444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro susceptibility of multidrug-resistant Enterobacteriaceae clinical isolates to tigecycline.
    Huang TD; Berhin C; Bogaerts P; Glupczynski Y
    J Antimicrob Chemother; 2012 Nov; 67(11):2696-9. PubMed ID: 22833638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nosocomial pneumonia.
    Preheim LC; Sanders WE
    Compr Ther; 1981 Jun; 7(6):20-7. PubMed ID: 7018827
    [No Abstract]   [Full Text] [Related]  

  • 32. Intraventricular administration of tigecycline for the treatment of multidrug-resistant bacterial meningitis after craniotomy: a case report.
    Wu Y; Chen K; Zhao J; Wang Q; Zhou J
    J Chemother; 2018 Feb; 30(1):49-52. PubMed ID: 28614982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of polymyxin B and fosfomycin combination to eradicate extensively antibiotic Klebsiella pneumoniae from the urine despite in-vitro activity.
    Arroyo JC; Allison-Ard C
    J S C Med Assoc; 2011; 107 Suppl():3-6. PubMed ID: 22057591
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic characterisation of clinical Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline: Role of the global regulator RamA and its local repressor RamR.
    Wang X; Chen H; Zhang Y; Wang Q; Zhao C; Li H; He W; Zhang F; Wang Z; Li S; Wang H
    Int J Antimicrob Agents; 2015 Jun; 45(6):635-40. PubMed ID: 25681067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of lower urinary tract infections with oral fosfomycin: a report of three cases.
    da Silva JO; Yu MC; Doi A; de Araujo MR; Neto PA; Furtado GH
    Rev Soc Bras Med Trop; 2015; 48(3):358-60. PubMed ID: 26108020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of liver abscess caused by tigecycline-nonsusceptible Klebsiella pneumoniae.
    Yang HS; Fang WL; Lin YT
    J Microbiol Immunol Infect; 2016 Aug; 49(4):621-2. PubMed ID: 27247260
    [No Abstract]   [Full Text] [Related]  

  • 37. Antibacterial activity of fosfomycin against uropathogens.
    Sun F; Chen S; Qiu X; Sun Y; Feng W; Chen J; Xia P
    Chemotherapy; 2014; 60(3):157-61. PubMed ID: 25792115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis.
    Stone NR; Woodford N; Livermore DM; Howard J; Pike R; Mushtaq S; Perry C; Hopkins S
    J Antimicrob Chemother; 2011 Nov; 66(11):2677-8. PubMed ID: 21846669
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta--lactamase-producing Klebsiella pneumoniae epidemic clone.
    Cobo J; Morosini MI; Pintado V; Tato M; Samaranch N; Baquero F; Cantón R
    Diagn Microbiol Infect Dis; 2008 Mar; 60(3):319-22. PubMed ID: 17996417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Favourable outcome in the treatment of carbapenem-resistant Enterobacteriaceae urinary tract infection with high-dose tigecycline.
    Brust K; Evans A; Plemmons R
    J Antimicrob Chemother; 2014 Oct; 69(10):2875-6. PubMed ID: 24879666
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.